Keith W Pratz
19PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Jan 09, 2026
Long-Term Outcomes of Stem Cell Transplant in Older Patients With Acute Myeloid Leukemia Treated With Venetoclax-Based Therapies.Keith W Pratz, Courtney D DiNardo, Martha Arellano
|Mar 29, 2025
Venetoclax and azacitidine in untreated patients with therapy-related acute myeloid leukemia, antecedent myelodysplastic syndromes or chronic myelomonocytic leukemia.Vinod Pullarkat, Keith W Pratz, Hartmut Döhner
|Feb 17, 2025
Frontline Therapy of AML in the Fit and Younger Population-Incorporating Molecularly Targeted Agents.Keith W Pratz, Harry P Erba
|Dec 23, 2024
Advancing the outcomes of AML out of antecedent MPN by targeting mutated IDH1.Keith W Pratz
|Nov 02, 2024
The impact of post-remission granulocyte colony-stimulating factor use in the phase 3 studies of venetoclax combination treatments in patients with newly diagnosed acute myeloid leukemia.Courtney D DiNardo, Keith W Pratz, Panayiotis Panayiotidis
|Feb 12, 2024
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia.Keith W Pratz, Brian A Jonas, Vinod Pullarkat
Pageof 4
Frequent Collaborators
10 joint publications
Courtney DiNardo
7 joint publications
Brian A Jonas
7 joint publications
Christian Recher
4 joint publications
Vinod Pullarkat
3 joint publications
Marina Konopleva
3 joint publications
Jessica K Altman
2 joint publications
Andrew H Wei
2 joint publications
Pau Montesinos
2 joint publications
Wellington Mendes
2 joint publications
Jacqueline S Garcia
